Huibo Ma
Impact in
-
- MicroRNA in disease regulation
-
- Advanced Drug Delivery Systems
Papers in
-
- Acute Kidney Injury Research 2
-
- MicroRNA in disease regulation 2
- Co-authors
- Yanyan Yang (5 shared papers)Xiuxiu Fu (4 shared papers)Xiaochun. Ma (7 shared papers)Tao Yu (4 shared papers)Xiaoxin Li (4 shared papers)Hongzhao Qi (3 shared papers)Min Ding (1 shared paper)Hongsheng Ren (1 shared paper)
- Journals
- Biomarkers in Medicine (1 paper)ACS Applied Materials & Interfaces (1 paper)Oxidative Medicine and Cellular Longevity (1 paper)Frontiers in Medicine (1 paper)Atherosclerosis (1 paper)
- Partner nations
- ChinaUnited States
In The Last Decade
Huibo Ma
13 papers receiving 320 citations
Peers
Comparison fields: 5 of 60
- Cancer Research 41
- Pharmaceutical Science 20
- Cardiology and Cardiovascular Medicine 51
- Nephrology 19
- Molecular Biology 100
Countries citing papers authored by Huibo Ma
This map shows the geographic impact of Huibo Ma's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Huibo Ma with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Huibo Ma more than expected).
Fields of papers citing papers by Huibo Ma
This network shows the impact of papers produced by Huibo Ma. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Huibo Ma. The network helps show where Huibo Ma may publish in the future.
Co-authors
The 25 scholars most cited alongside Huibo Ma, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 64 | |
| 2 | 2022 | 46 | |
| 3 | 2022 | 45 | |
| 4 | 2022 | 44 | |
| 5 | 2020 | 42 | |
| 6 | 2022 | 25 | |
| 7 | 2022 | 23 | |
| 8 | 2021 | 15 | |
| 9 | 2020 | 10 | |
| 10 | 2020 | 5 | |
| 11 | 2022 | 4 | |
| 12 | 2024 | 2 | |
| 13 | 2023 | 1 | |
| 14 | 2020 | 0 | |
| 15 | 2023 | 0 |
About Huibo Ma
Huibo Ma is a scholar working on Nephrology, Cancer Research, Pulmonary and Respiratory Medicine, Cardiology and Cardiovascular Medicine and Biochemistry, having authored 15 papers that have together received 326 indexed citations. Recurring topics across this work include RNA Interference and Gene Delivery (2 papers), Aortic aneurysm repair treatments (2 papers), Cardiac Valve Diseases and Treatments (2 papers), Acute Kidney Injury Research (2 papers), MicroRNA in disease regulation (2 papers), Cancer-related gene regulation (2 papers), Aortic Disease and Treatment Approaches (2 papers) and Epigenetics and DNA Methylation (1 paper). The work is most often cited by research in Cancer Research (41 citations), Pharmaceutical Science (20 citations), Cardiology and Cardiovascular Medicine (51 citations), Nephrology (19 citations) and Molecular Biology (100 citations). Huibo Ma has collaborated with scholars based in China and United States. Frequent co-authors include Yanyan Yang, Xiuxiu Fu, Xiaochun. Ma, Tao Yu, Xiaoxin Li, Hongzhao Qi, Min Ding, Hongsheng Ren, Xiaoming Zhou and Lu Zou. Their work appears in journals such as Biomarkers in Medicine, ACS Applied Materials & Interfaces, Oxidative Medicine and Cellular Longevity, Frontiers in Medicine and Atherosclerosis.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.